SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-008968
Filing Date
2016-11-01
Accepted
2016-11-01 16:02:13
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20160930x10q.htm 10-Q 1363310
2 EX-31.1 idra-20160930ex311c31620.htm EX-31.1 14410
3 EX-31.2 idra-20160930ex312241f17.htm EX-31.2 14420
4 EX-32.1 idra-20160930ex321e74f3d.htm EX-32.1 6714
5 EX-32.2 idra-20160930ex322fcc215.htm EX-32.2 6554
  Complete submission text file 0001558370-16-008968.txt   4547194

Data Files

Seq Description Document Type Size
6 EX-101.INS idra-20160930.xml EX-101.INS 918489
7 EX-101.SCH idra-20160930.xsd EX-101.SCH 34511
8 EX-101.CAL idra-20160930_cal.xml EX-101.CAL 47458
9 EX-101.DEF idra-20160930_def.xml EX-101.DEF 97967
10 EX-101.LAB idra-20160930_lab.xml EX-101.LAB 236885
11 EX-101.PRE idra-20160930_pre.xml EX-101.PRE 201047
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 161964757
SIC: 2836 Biological Products, (No Diagnostic Substances)